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Wnt activation protects against neomycin-induced hair
cell damage in the mouse cochlea
L Liu1,2,8, Y Chen1,3,4,8, J Qi5,6, Y Zhang1,3,4, Y He1,3,4, W Ni1,4, W Li1,3,4, S Zhang5,6, S Sun1,3,4, MM Taketo7, L Wang2, R Chai*,5,6 and
H Li*,1,2,4
Recent studies have reported the role of Wnt/β-catenin signaling in hair cell (HC) development, regeneration, and differentiation in
the mouse cochlea; however, the role of Wnt/β-catenin signaling in HC protection remains unknown. In this study, we took
advantage of transgenic mice to specifically knockout or overactivate the canonical Wnt signaling mediator β-catenin in HCs,
which allowed us to investigate the role of Wnt/β-catenin signaling in protecting HCs against neomycin-induced damage. We first
showed that loss of β-catenin in HCs made them more vulnerable to neomycin-induced injury, while constitutive activation of
β-catenin in HCs reduced HC loss both in vivo and in vitro. We then showed that loss of β-catenin in HCs increased caspase-
mediated apoptosis induced by neomycin injury, while β-catenin overexpression inhibited caspase-mediated apoptosis. Finally, we
demonstrated that loss of β-catenin in HCs led to increased expression of forkhead box O3 transcription factor (Foxo3) and Bim
along with decreased expression of antioxidant enzymes; thus, there were increased levels of reactive oxygen species (ROS) after
neomycin treatment that might be responsible for the increased aminoglycoside sensitivity of HCs. In contrast, β-catenin
overexpression reduced Foxo3 and Bim expression and ROS levels, suggesting that β-catenin is protective against neomycin-
induced HC loss. Our findings demonstrate that Wnt/β-catenin signaling has an important role in protecting HCs against
neomycin-induced HC loss and thus might be a new therapeutic target for the prevention of HC death.
Cell Death and Disease (2016) 7, e2136; doi:10.1038/cddis.2016.35; published online 10 March 2016
Inner ear hair cells (HCs) are responsible for hearing.
Aminoglycosides can be ototoxic and induce caspase-
mediated apoptosis in HCs. During mammalian inner ear
development, canonical Wnt signaling is critical for otocyst
induction and directs the formation of the vestibular organs.1,2
Wnt signaling also has an important role in the cochlear HC
development, and knockout of β-catenin inhibits HC differ-
entiation from sensory progenitors thus reducing HC
generation.3,4 Recently, the Wnt signaling downstream target
genes Lgr5 and Axin2 have been reported to mark inner ear
HC progenitors. Lgr5-positive HC progenitors can self-renew
to regenerate HCs after isolation in vitro and can sponta-
neously regenerate HCs after HC damage in the neonatal
mouse cochlea in vivo.5–10 Recent studies have also shown
that Wnt signaling has dual roles in controlling the proliferation
and differentiation of HC progenitors;3,4 however, the role of
Wnt/β-catenin signaling in HC survival and damage protection
in the mouse cochlea remains unclear.
In other organs, the Wnt/β-catenin signaling pathway has
been shown to function in various cell processes, including
cellular protection.11–15 The pro-survival activity of the Wnt
pathway has been reported in many tissues, and is believed
to be mediated by the induction of specific anti-apoptotic
genes.16,17 For example, in retinal ganglion cells Wnt activa-
tion reduces apoptosis by increasing the expression of
protective growth factors including NT3, BDNF, and NGF.11
In the intestine, overexpression of Wnt2a glycoprotein ligand
of the Wnt proteins decreases bacterial-induced intestinal
epithelial cell death. In the liver, Wnt/β-catenin signaling acts
as a transcriptional co-activator of hypoxia inducible factor-1α
signaling and has a protective role against hypoxia-induced
liver injury. Forkhead box O3 transcription factor (Foxo3) and
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Bim, which belong to the BCL-2 family members and are the
downstream target gene of Foxo3,18 have been reported to
regulate the expression of stress-response proteins and to be
involved in apoptosis in multiple organs.19–21 Overactivation of
Wnt signaling inhibits Foxo3-induced apoptosis through
upregulation of serum and glucocorticoid-inducible kinase 1
(SGK1),22 and overexpression of Wnt/β-catenin signaling
inhibits Foxo3 signaling in 3,5-diethoxycarbonyl-1,4-dihydro-
collidine (DDC)-induced liver injury.23 However, the protective
role of Wnt/β-catenin signaling against neomycin-induced HC
loss in the mouse inner ear has been unclear.
In this study, we used loss-of-function and gain-of-function
mouse models to investigate the role of Wnt/β-catenin
signaling in protecting HCs against aminoglycoside-induced
ototoxicity in the mouse cochlea both in vivo and in vitro. We
found that β-catenin regulates Foxo3 and Bim expression and
controls reactive oxygen species (ROS) levels, thus protecting
HCs against caspase-mediated apoptosis after neomycin
injury.
Results
Specifically knockout or overactivate β-catenin in HCs.
β-Catenin loss-of-function and gain-of-function experiments
were performed using Gfi1-Cre/β-cateninflox(exon2–6) and
Gfi1-Cre/β-cateninflox(exon3) mice to specifically knockout or
overactivate β-catenin in HCs. Consistent with a previous
Figure 1 Manipulation of β-catenin expression in mouse cochlear HCs. (a and b) Gfi1-Cre efficiency was tested using Gfi1-Cre/Rosa26-tdTomato mice. Tomato fluorescence
showed that Gfi1-Cre activity is similar in inner and outer HCs at all turns in postnatal day (P) 2 Gfi-Cre/tdTomato mice. (c) The tdTomato-positive HCs were isolated using flow
cytometry. (d and e) Western blot and immunofluorescence revealed the increased expression of β-catenin in Gfi1-Cre/β-cateninflox(exon3) mice and decreased expression of
β-catenin in Gfi1-Cre/β-cateninflox(exon2–6) mice. (f) qPCR results showed that Wnt target genes, Axin2 and Lgr5, were upregulated in Gfi1-Cre/β-cateninflox(exon3) mice and
downregulated in Gfi1-Cre/β-cateninflox(exon2–6) mice. (g) FM1-43 immunofluorescence revealed normal function of mechanotransduction channels in Gfi1-Cre/β-cateninflox(exon3)
and Gfi1-Cre/β-cateninflox(exon2–6) mice. Scale bar: 500 μm (a); 20 μm (b, d and g). *Po0.05; **Po0.01; ***Po0.001. n= 5
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report,24 we found that Cre is activated in 98.76±0.33% of the
HCs and Cre activity is similar among the three turns by using
Gfi1-Cre/Rosa26-tdTomato mice (Figures 1a and b). Immuno-
histochemistry results demonstrated that β-catenin express-
ion in HCs was decreased in Gfi1-Cre/β-cateninflox(exon2–6)
mice and increased in Gfi1-Cre/β-cateninflox(exon3) mice
(Figure 1d). To further test the β-catenin knockout
or overactivation efficiency in HCs, we generated
Gfi1-Cre/β-cateninflox(exon2–6)/Rosa26-tdTomato and Gfi1-
Cre/β-cateninflox(exon3)/Rosa26-tdTomato mice and isolated
the tdTomato-positive HCs using flow cytometry (Figure 1c).
Western blot results revealed that the protein expres-
sion of β-catenin in HCs was significantly decreased
in Gfi1-Cre/β-cateninflox(exon2–6) mice and increased in
Gfi1-Cre/β-cateninflox(exon3) mice (Figure 1e). The activation
level of Wnt signaling in HCs was further confirmed by the
mRNA expression of the Wnt downstream target genes
Axin2 and Lgr5. Quantitative real-time PCR (qPCR) results
showed that the mRNA expression of Axin2 and Lgr5 in HCs
were both significantly decreased in Gfi1-Cre/β-cateninflox
(exon2–6) mice and increased in Gfi1-Cre/β-cateninflox(exon3)
mice (Figure 1f). Finally, FM1-43, a marker of functional
Figure 2 Knockout of β-catenin makes HCs more vulnerable to neomycin-induced ototoxicity in vivo. (a) The diagram of the assay for (b and c). Cochlear sensory epithelium
samples from P2 wild-type mice were dissected out and allowed to recover for 12 h. The samples were treated with 1 mM neomycin for 6 h, allowed to recover for 3 h, and then
used for immunostaining and western blot experiments. Samples for qPCR were collected at 0, 3, 6, 9, and 12 h after the beginning of neomycin treatment. (b and c)
Immunofluorescence and western blot revealed the increased β-catenin expression in the HCs after neomycin injury. (d) qPCR results showed that the expression of β-catenin
and the Wnt target genes Axin2 and Lgr5 were significantly upregulated after neomycin injury. ***Po0.001, **Po0.01, n= 5, versus no neomycin group. (e) The diagram of
the assay for (f and g). Cochlear sensory epithelium samples from P2 Gfi1-Cre/β-cateninflox(exon2-6) mice were dissected out and allowed to recover for 12 h. The samples
were treated with 1 mM neomycin for 6 h, allowed to recover for 24 h, and then stained with Myosin antibody. Littermates lacking the Gfi1-Cre allele were used as controls.
(f and g) β-Catenin knockout mice had significantly greater HC loss than control mice in the apical and middle turns of the cochlea after neomycin treatment in newborn mice.
Scale bar= 20 μm. ***Po0.001, **Po0.01, n= 5
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mechanotransduction channels in HCs, was used to detect
the mechanotransduction function of HCs in transgenic mice.
FM1-43 staining revealed normal function of mechanotrans-
duction channels in HCs in both Gfi1-Cre/β-cateninflox(exon2–6)
and Gfi1-Cre/β-cateninflox(exon3) mice (Figure 1g).
The Wnt/β-catenin pathway was activated in the cochlear
HCs after neomycin injury. We next explored the expres-
sion of β-catenin and Wnt target genes in the cochlear HCs
after neomycin treatment. Both immunofluorescence and
western blot results revealed increased β-catenin expression
in the HCs after neomycin injury (Figures 2b and c). qPCR
results showed that the expression of β-catenin and the Wnt
target genes Axin2 and Lgr5 were significantly upregulated
after neomycin treatment (Figure 2d). These results
demonstrated that the Wnt/β-catenin pathway was activated
in the cochlear HCs after neomycin injury, indicating that
Wnt/β-catenin might be a protective physiological mechanism
against neomycin injury.
Knockout of β-catenin makes the HCs more vulnerable to
neomycin-induced ototoxicity in vitro. In this experiment,
cochlear sensory epithelium samples from postnatal day (P)
2 Gfi1-Cre/β-cateninflox(exon2–6) and control mice were cul-
tured in vitro and treated with neomycin. Without neomycin,
there were no reductions in HCs either in control cochleae or
in Gfi1-Cre/β-cateninflox(exon2–6) cochleae (Figures 2f and g).
With neomycin treatment, Gfi1-Cre/β-cateninflox(exon2–6)
cochleae had significantly greater HC loss than control
cochleae in the apical and middle turns (Figures 2f and g
and Supplementary Table 1). This result suggested that
β-catenin has an important role in regulating the sensitivity of
cochlear HCs to neomycin-induced injury.
Overactivation of the Wnt/β-catenin signaling pathway
protects against neomycin-induced HC damage
in vitro. To investigate the protective role of β-catenin
against neomycin-induced HC damage, we used the Wnt
agonist Bio and β-catenin overexpressing transgenic mice in
two independent in vitro experiments. First, cochlear sensory
epitheliums from P2 wild-type (WT) mice were cultured with
Bio (5 μM) for 48 h (Figure 3a). Immunofluorescence results
demonstrated upregulated expression of β-catenin in Bio-
treated HCs (Figure 3b). qPCR data showed that Bio-treated
cochleae had significantly higher expression of the Wnt
downstream target genes Lgr5 and Axin2 than the control
group (Figure 3c). When treated with neomycin in the
presence of Bio, Myosin7a staining showed that Bio-treated
cochleae had significantly less HC loss than the control
cochleae in all three turns (Figures 3d and e and
Supplementary Table 1), which suggested that Wnt/β-catenin
signaling could protect HCs against neomycin-induced
damage in vitro.
In a separate experiment, we investigated the protective role
of β-catenin using Gfi1-Cre/β-cateninflox(exon3) transgenic mice.
Compared with control cochleae, Gfi1-Cre/β-cateninflox(exon3)
cochleae had significantly reduced HC loss in all three turns
after neomycin treatment (Figures 3g and h and Supplementary
Table 1), which was consistent with the Wnt agonist treat-
ment and demonstrated that overexpression of Wnt/β-catenin
protects against neomycin-induced HC damage in vitro.
Knockout of β-catenin in HCs leads to partial hearing
loss and scattered HC loss in vivo. To investigate the role
of β-catenin in HC survival in vivo, we measured hearing
function of Gfi1-Cre/β-cateninflox(exon2–6) mice using pure-tone
auditory brainstem response (ABR) and then dissected out
the cochlear sensory epithelium for immunohistochemistry
staining at P30 and P60 (Figure 4a). The same litter control
mice have normal hearing, and no HC loss was observed at
P30 or P60 (Figures 4b and d). In Gfi1-Cre/β-cateninflox(exon2–6)
mice, we observed a 5–10 dB threshold shift at P30 and a
5–15 dB threshold shift at P60 compared with controls
(Figures 4c and d). We also found scattered HC loss in
middle and basal turns, but the total HC number showed no
significant difference compared with controls at P30 and P60
(Figures 4e and f). These results demonstrated that deletion
of β-catenin in HCs leads to partial hearing loss and scattered
HC loss in vivo.
Overexpression of Wnt/β-catenin protects against
neomycin-induced hearing loss and HC loss
in vivo. Here, Gfi1-Cre/β-cateninflox(exon3) transgenic mice
were given daily subcutaneous injections of neomycin from
P7 to P14, which is the ototoxic-sensitive period in the
cochlea.25 At P30 and P60, we measured hearing function
and then dissected out the cochlear sensory epithelium for
immunohistochemistry staining (Figure 5a). Control mice had
significant hearing loss, and the ABR thresholds were
significantly increased at all frequencies at both P30 and
P60 (Figure 5c). In Gfi1-Cre/β-cateninflox(exon3) mice, the ABR
threshold shifts were significantly lower at all frequencies
compared with the control littermates at both P30 and P60
(Figure 5c), suggesting that overexpression of Wnt/β-catenin
protects against neomycin-induced hearing loss in vivo.
Immunohistochemistry results showed that Gfi1-Cre/β-cate-
ninflox(exon3) mice had significantly reduced outer hair cell
(OHC) loss compared with the control littermates at both P30
and P60 (Figures 5b, d and e and Supplementary Table 2).
This demonstrated that overexpression of Wnt/β-catenin
Figure 3 Upregulating the Wnt pathway protects against neomycin-induced HC damage. (a) The diagram of the assay for (d and e). (b) P2 cochlear sensory epithelium
samples were treated with Bio (5 μM) for 48 h in the absence of neomycin. PBS treatment was the vehicle control. Immunofluorescence photo showed upregulated expression of
β-catenin in the Bio-treated group (middle turn, HC layer). (c) The Wnt target genes Axin2 and Lgr5 were upregulated after Bio treatment. (d) Bio-treated cochleae
had significantly reduced HC loss after neomycin treatment. (e) The numbers of Myosin-positive cells in the Bio-treated and control cochleae. (f) The diagram of the assay for
(g and h). Cochlear sensory epithelium samples from P2 Gfi1-Cre/β-cateninflox(exon3) transgenic mice were dissected out and treated with 1 mM neomycin for 6 h, allowed to
recover for 24 h, and then stained with the Myosin7a antibody. Littermates lacking the Gfi1-Cre allele were used as controls. (g) Representative photo of Myosin-positive HCs after
neomycin treatment in controls and Gfi1-Cre/β-cateninflox(exon3) mice. (h) Statistical data showing that Gfi1-Cre/β-cateninflox(exon3) transgenic mice had more Myosin7a-positive
HCs in the apical, middle, and basal turns of the cochlear epithelium. Scale bar= 20 μm. *Po0.05; **Po0.01; ***Po0.001. n= 5
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Figure 4 Knockout of β-catenin in HCs leads to partial hearing loss and scattered HC loss in vivo. (a) The scheme of the assay. Gfi1-Cre/β-cateninflox(exon2–6) transgenic mice
were analyzed at P30 and P60 without neomycin treatment. (b and c) Pure-tone ABR data showed partial hearing loss at P30 and P60 in Gfi1-Cre/β-cateninflox(exon2–6) mice
compared with control groups. (d) Myosin7a immunofluorescence showed scattered HC loss in the middle and basal turns in Gfi1-Cre/β-cateninflox(exon2-6) transgenic mice.
(e and f) Statistical data showing that the total HC number was not significantly different between Gfi1-Cre/β-cateninflox(exon2–6) and control mice. Scale bar= 20 μm. n= 5
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protects against neomycin-induced OHC loss in vivo. There
was almost no inner hair cell (IHC) loss in either Gfi1-Cre/β-
cateninflox(exon3) mice or control littermates at P30 or P60
(Figures 5b and f).
Wnt/β-catenin regulates the caspase-mediated apoptosis
induced by neomycin injection in vivo. Previous studies
reported that neomycin kills HCs through the induction of
apoptosis;25–27 thus, we investigated the expression of
apoptosis-related genes after neomycin injury in vivo.
Gfi1-Cre/β-cateninflox(exon3) and Gfi1-Cre/β-cateninflox(exon2–6)
mice were treated with neomycin and were killed 3 days after
the last injection (Figure 6a). Immunohistochemistry data
showed that Gfi1-Cre/β-cateninflox(exon3) cochleae had no
parvalbumin/caspase-3 double-positive cells in all three
turns, while Gfi1-Cre/β-cateninflox(exon2–6) cochleae had sig-
nificantly more parvalbumin/caspase-3 double-positive cells
in the middle turn compared with the control littermates
(Figures 6b and d and Supplementary Table 3). qPCR data
showed that Gfi1-Cre/β-cateninflox(exon3) mice had signifi-
cantly lower expression of the pro-apoptotic genes Casp3,
Casp9, Bax, p53, and Apaf1 (Figure 6e), while Gfi1-Cre/β-
cateninflox(exon2–6) mice had significantly higher expression of
pro-apoptotic genes (Figure 6e). These results demonstrated
Figure 5 Overexpression of Wnt/β-catenin protects against neomycin-induced hearing loss and HC loss in vivo. (a) The scheme of the assay. Gfi1-Cre/β-cateninflox(exon3)
transgenic mice were given daily subcutaneous injections of neomycin (200 mg/kg) from P7 to P14. At P30 and P60, hearing function was measured by using pure-tone ABR and
then the cochlear sensory epithelium was dissected out for immunohistochemistry staining. (b) Myosin7a immunofluorescence in P30 and P60 mice after the injection of
neomycin or saline. (c) ABR data in P30 and P60 mice. (d) The numbers of Myosin-positive OHC in P30 mice. (e) The numbers of Myosin-positive OHC in P60 mice. (f) The
numbers of Myosin-positive IHC in P30 and P60 mice. Scale bar= 20 μm. *Po0.05; ***Po0.001. n= 5
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that Wnt/β-catenin signaling could regulate the caspase-
mediated apoptosis induced by neomycin injection in vivo.
Caspase-mediated HC apoptosis is regulated by Wnt/β-
catenin signaling in HCs after neomycin injury
in vitro. After neomycin treatment in vitro, Gfi1-Cre/β-
cateninflox(exon3) cochleae had significantly fewer TUNEL/
Myosin7a double-positive cells compared with the control
littermates, while Gfi1-Cre/β-cateninflox(exon2–6) cochleae had
significantly more TUNEL/Myosin7a double-positive cells in
the apical and middle turns (Figures 7b and d and
Supplementary Table 4). qPCR data showed that the
expression of pro-apoptotic genes Casp3, Casp9, Bax, p53,
and Apaf1 was significantly reduced in Gfi1-Cre/β-cateninflox
(exon3) cochleae compared with controls and was significantly
increased in Gfi1-Cre/β-cateninflox(exon2–6) cochleae
(Figure 7e). These results demonstrated that Wnt/β-catenin
signaling in HCs inhibits the caspase-mediated apoptosis
induced by neomycin in vitro.
Foxo3 expression is regulated by Wnt/β-catenin signal-
ing in HCs after neomycin injury. Previous studies
have reported that Wnt/β-catenin inhibits the pro-apoptotic
transcription factor Foxo3 and protects against oxidative
stress-induced apoptosis though downregulation of
Foxo3.14,15,28 We investigated the Foxo3 expression in
neomycin-treated cochleae. At 6 h after neomycin treat-
ment, intense nuclear Foxo3 staining was observed in control
HCs, which is indicative of active Foxo3 signaling in response
to neomycin-induced HC damage (Figure 8b). In Gfi1-Cre/β-
cateninflox(exon3) cochleae, HCs had significantly reduced Foxo3
staining intensity (Figure 8b). In Gfi1-Cre/β-cateninflox(exon2–6)
cochleae, HCs had significantly greater Foxo3 staining
intensity (Figure 8b). qPCR and western blot data
showed that Foxo3 expression was significantly reduced in
Gfi1-Cre/β-cateninflox(exon3) cochleae and significantly
increased in Gfi1-Cre/β-cateninflox(exon2–6) cochleae com-
pared with the controls (Figures 8d and e). Bim is one of
the BCL-2 family members participating in the progress of
apoptosis, and is the downstream target gene of Foxo3.18
qPCR data revealed that Bim expression was also
significantly decreased in Gfi1-Cre/β-cateninflox(exon3)
cochleae and increased in Gfi1-Cre/β-cateninflox(exon2–6)
cochleae (Figure 8d). These results suggested that after
neomycin injury Foxo3 and Bim expression was inhibited
when β-catenin was overexpressed in HCs and increased
Figure 6 Wnt/β-catenin regulates the caspase-mediated apoptosis that is induced by neomycin injection in vivo. (a) The scheme of the assay. Mice were given daily
subcutaneous injections of neomycin (200 mg/kg) from P7 to P14. At P17, cochlear sensory epithelium samples were dissected out. The age-matched littermates lacking the
Gfi1-Cre allele were used as controls. (b) Representative confocal images of the HC marker parvalbumin and the apoptosis marker cleaved caspase-3 (Casp3)
immunofluorescence in P17 mice (middle turn, HC layer). (c) Parvalbumin-positive HC quantification in OHCs in P17 mice. (d) Statistical data showing that Parvalbumin/Casp3
double-positive cells significantly increased in Gfi1-Cre/β-cateninflox(exon2–6) mice and decreased in Gfi1-Cre/β-cateninflox(exon3) mice. (e) qPCR analysis showed that Casp3,
Casp9, Bax, p53, and Apaf1 expression increased in Gfi1-Cre/β-cateninflox(exon2–6) mice and decreased in Gfi1-Cre/β-cateninflox(exon3) mice after neomycin damage. Scale
bar= 20 μm. *Po0.05; **Po0.01; ***Po0.001. n= 5 (e) or 8 (b–d)
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when β-catenin was knocked out in HCs. We also noticed that
the mRNA expression of Foxo1, which is another member of
the Foxo protein superfamily, was not significantly changed
(Figure 8d), suggesting that Foxo1 might not be regulated by
Wnt signaling in the cochlea.
Furthermore, we investigated the expression level of Foxo3
after 2 h neomycin treatment, at which time no obvious HC
loss has occurred yet. Immunohistochemistry results showed
that HCs had significantly reduced Foxo3 expression in
Gfi1-Cre/β-cateninflox(exon3) cochleae and had significantly
higher Foxo3 expression in Gfi1-Cre/β-cateninflox(exon2–6)
cochleae (Figure 8b). qPCR data also demonstrated that the
expression of Foxo3 was significantly decreased in Gfi1-Cre/
β-cateninflox(exon3) cochleae and significantly increased in
Gfi1-Cre/β-cateninflox(exon2–6) cochleae (Figure 8c). The
expression of Sgk1, which is a β-catenin target gene and the
upstream inhibitor of Foxo3 activity,23 was significantly
increased in Gfi1-Cre/β-cateninflox(exon3) cochleae and sig-
nificantly decreased in Gfi1-Cre/β-cateninflox(exon2–6) cochleae
(Figure 8c). Altogether, these results suggested that Foxo3
expression in HCs is regulated by Wnt/β-catenin signaling
after neomycin injury.
ROS levels in HCs are regulated by Wnt/β-catenin
signaling after neomycin injury. Previous studies reported
that Foxo3 is required for the regulation of oxidative stress,18,29
and Wnt/β-catenin has been reported to protect against
oxidative stress-induced apoptosis in many organs.14,15 In
the mouse cochlea, aminoglycoside-induced accumulation of
ROS is closely related to HC apoptosis.30 In this experiment,
we used MitoSOX Red, a redox fluorophore that selectively
detects mitochondrial superoxide,31–33 to evaluate mitochon-
drial ROS generation in HCs after neomycin treatment
(Figure 9a). Results showed that Gfi1-Cre/β-cateninflox(exon3)
cochleae had significantly fewer MitoSOX/Myosin7a double-
positive cells in all three turns compared with control, and
Gfi1-Cre/β-cateninflox(exon2–6) cochleae had significantly more
MitoSOX/Myosin7a double-positive cells in the apical turn
(Figures 9b and c and Supplementary Table 5). These results
suggested that mitochondrial ROS levels in HCs are
significantly reduced in Gfi1-Cre/β-cateninflox(exon3) mice and
significantly increased in Gfi1-Cre/β-cateninflox(exon2–6) mice. To
find out how Wnt/β-catenin regulates ROS levels in β-catenin
overexpressed/knockout HCs, qPCR was used to investigate
the expression levels of several antioxidant enzymes (Nqo1, Cat,
Figure 7 Caspase-mediated HC apoptosis is regulated by Wnt/β-catenin signaling in HCs after neomycin injury in vitro. (a) The scheme of the assay. Cochlear sensory
epithelium samples were dissected out from P2 Gfi1-Cre/β-cateninflox(exon3) and Gfi1-Cre/β-cateninflox(exon2–6) mice, then cultured with 1 mM neomycin for 6 h and allowed to
recover for 6 h before analysis. (b) Representative confocal images of TUNEL and Myosin immunofluorescence (middle turn, HC layer). (c) Numbers of Myosin-positive HCs after
neomycin treatment. (d) Statistical data showing that TUNEL/Myosin double-positive cells significantly increased in Gfi1-Cre/β-cateninflox(exon2–6) mice and decreased in Gfi1-Cre/
β-cateninflox(exon3) mice. (e) qPCR analysis showing that Casp3, Casp9, Bax, p53, and Apaf1 expression increased in Gfi1-Cre/β-cateninflox(exon2–6) mice and decreased in
Gfi1-Cre/β-cateninflox(exon3) mice after neomycin damage. Scale bar= 20 μm. *Po0.05; **Po0.01; ***Po0.001. n= 5
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Sod1, Sod2, and Gsr). Results showed that antioxidant genes
expression, including Sod2, Cat, and Gsr, were significantly
increased in Gfi1-Cre/β-cateninflox(exon2–6) mice but significantly
decreased in Gfi1-Cre/β-cateninflox(exon3) mice (Figure 9d).
All of these results demonstrated that Wnt/β-catenin signaling
regulates neomycin-induced ROS accumulation in HCs.
Antioxidant treatment rescues β-catenin deficiency-
induced HC loss after neomycin injury. To further
investigate whether the increase in ROS levels contributes
to the increased injury sensitivity to aminoglycosides of
β-catenin-deficient HCs, the antioxidant N-acetylcysteine
(NAC), which is a reduced glutathione provider and a direct
scavenger of reactive oxygen intermediates,34 was used to
treat the explant cultured cochlea with neomycin injury. After
NAC treatment, HC loss dramatically decreased in both
Gfi1-Cre/β-cateninflox(exon2–6) and control mice, and the
number of surviving HCs was not significantly different
between Gfi1-Cre/β-cateninflox(exon2–6) and control mice
(Figures 10b and c). Moreover, MitoSOX Red immunofluor-
escence showed that ROS levels significantly decreased in
HCs of Gfi1-Cre/β-cateninflox(exon2–6) mice after NAC treat-
ment (Figures 10e and f), suggesting that the rescue of the
HCs was associated with a decrease in oxidative stress.
Together, these results showed that antioxidant treatment
successfully rescued the β-catenin deficiency-induced HC
loss in Gfi1-Cre/β-cateninflox(exon2–6) mice after neomycin
injury, and demonstrated that ROS accumulation was the
Figure 8 Foxo3 expression is regulated by Wnt/β-catenin signaling in HCs after neomycin injury. (a) The scheme of the assay. In the first experiment, P2 mouse cochlear
epithelium samples were cultured with neomycin for 2 h. In the second experiment, P2 mouse cochlear epithelium samples were cultured with neomycin for 6 h and then allowed
to recover for 6 h before analysis. (b) Parvalbumin and Foxo3 immunofluorescence showed that Foxo3 expression increased in Gfi1-Cre/β-cateninflox(exon2–6) mice and decreased
in Gfi1-Cre/β-cateninflox(exon3) mice after neomycin damage (middle turn, HC layer). (c and d) qPCR data showed the mRNA expression level of Sgk1, Foxo3, Foxo1, and Bim
after neomycin treatment. (e) Western blot showed that Foxo3 expression increased in Gfi1-Cre/β-cateninflox(exon2–6) mice and decreased in Gfi1-Cre/β-cateninflox(exon3) mice after
neomycin damage. Scale bar= 20 μm. *Po0.05; **Po0.01; ***Po0.001. n= 5 (b, c, and e) or 8 (d)
Wnt activation protects cochlear hair cells
L Liu et al
10
Cell Death and Disease
major cause of the high injury sensitivity to aminoglycosides
in β-catenin-deficient HCs.
Discussion
The role of Wnt/β-catenin signaling in cochlear development
and HC regeneration has been extensively studied in the
mouse inner ear. Recently, Wnt/β-catenin has been reported
to be required for HC differentiation in the mouse cochlea.
Knockout of β-catenin inhibits prosensory cells from differ-
entiating into HCs, but β-catenin is not required to maintain HC
fate once it is specified.4 However, whether Wnt/β-catenin
signaling is required for HC survival has not been investigated.
In this study, we observed increased susceptibility of HCs to
Figure 9 ROS levels in HCs are regulated by Wnt/β-catenin signaling after neomycin injury. (a) The scheme of the assay. Cochlear epithelium samples were dissected out
and cultured with 1 mM neomycin for 6 h and allowed to recover for 6 h before analysis. (b) Myosin7a and MitoSOX Red immunofluorescence showed that ROS levels increased
in Gfi1-Cre/β-cateninflox(Ex2–6) mice and decreased in Gfi1-Cre/β-cateninflox(exon3) mice after neomycin damage (middle turn, HC layer). (c) The numbers of Myosin7a/MitoSOX
Red double-positive cells. (d) qPCR results showed that antioxidant gene expression significantly decreased Gfi1-Cre/β-cateninflox(exon2–6) mice but significantly increased in
Gfi1-Cre/β-cateninflox(exon3) mice. Scale bar= 20 μm. *Po0.05; **Po0.01; ***Po0.001. n= 5
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neomycin treatment in Gfi1-Cre/β-cateninflox(exon2–6) mice,
which indicated that β-catenin might have an important role
in protecting the sensory HCs.
Previous studies reported that several pathways are
involved in β-catenin deficiency-induced cell death, including
increased apoptosis of hepatic progenitor cells due to
enhanced expression of cleaved caspase-9 and caspase-3
when β-catenin expression is blocked,16 increased apoptosis
in cisplatin-resistant lung adenocarcinoma cells when DKK3 is
used to inhibit the Wnt/β-catenin pathway,35 and increased si-
LGR5-induced apoptosis when the mitochondrial membrane
potential is disrupted in colorectal cancer cells.36 In our study,
significantly greater HC loss was observed in β-catenin
knockout cochleae compared with controls after neomycin
treatment (Figure 2), which was accompanied by upregulation
of the pro-apoptotic transcription factor Foxo3 and its down-
stream target gene Bim (Figure 8). Foxo3 is a pro-apoptotic
transcription factor that regulates the expression of stress-
response proteins and leads to apoptosis in many
tissues.19–21 In neuronal cells, activation of Foxo3 induces
two sequential ROS waves by induction of its transcriptional
target Bim.18 ROS can oxidize cell constituents, such as DNA,
and can lead to DNA damage that activates multiple apoptotic
pathways, including caspase-mediated apoptosis and
p53-dependent apoptosis.37–39 Foxo3 also activates an ROS
rescue pathway by inducing Sestrin3, which is responsible
for the biphasic ROS accumulation.18 Previous studies
have reported that Wnt/β-catenin protects against oxidative
Figure 10 The NAC rescue assay. (a) The scheme of the assay for (b and c). P2 Gfi1-Cre/β-cateninflox(exon2–6) cochlear epithelium samples were dissected out and cultured
with 1 mM neomycin for 6 h with NAC (20 μM), then allowed to recover for 24 h in the presence of NAC before analysis. (b) Myosin7a immunofluorescence showed that NAC
treatment rescued β-catenin-deficient HCs from neomycin injury. (c) Statistical data showing that the number of surviving HCs was not significantly different between Gfi1-Cre/β-
cateninflox(exon2–6) and control mice after NAC treatment. (d) The scheme of the assay for (e and f). P2 Gfi1-Cre/β-cateninflox(exon2–6) cochlear epithelium samples were dissected
out and cultured with 1 mM neomycin for 6 h with NAC (20 μM), then allowed to recover for 6 h in the presence of NAC before analysis. (e) MitoSOX Red immunofluorescence
showed that ROS levels significantly decreased in the HCs of Gfi1-Cre/β-cateninflox(exon2–6) mice after NAC treatment. (f) The number of Myosin7a/MitoSOX Red double-positive
cells. Scale bar= 20 μm. ***Po0.001. n.s., no significant difference. n= 5
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stress-induced apoptosis through downregulation of
Foxo3.14,15,28 In β-catenin-deficient cochleae, we found that
upregulation of Foxo3 expression was accompanied by
decreased expression of antioxidant enzymes (Figure 9),
increased mitochondrial ROS accumulation (Figure 9), and
significantly higher expression levels of Casp3, Casp9, Bax,
Apaf1, and p53 (Figures 6 and 7), suggesting that the
increased susceptibility of β-catenin-deficient HCs to neo-
mycin treatment is attributed to Foxo3 activation and ROS
accumulation. The precise role of Foxo3 in the oxidative stress
in cochlear HCs needs to be investigated in the future.
Previous studies reported that several genes have protec-
tive functions against aminoglycoside-induced HC loss. Over-
expression of XIAP inhibits caspase expression and prevents
neomycin-induced HC death and subsequent hearing loss.25
Insulin-like growth factor 1 (IGF-1) protects HCs from
aminoglycosides by upregulating growth-associated protein
43 and netrin 1.40 In many organs and cell lines,Wnt/β-catenin
has been reported to have a protective function against
apoptosis. In human HCT116 colon cancer cells,
Wnt/β-catenin negatively regulates the pro-apoptotic tran-
scription factor Foxo3 and inhibits Foxo3-induced apoptosis.28
In the liver, Wnt/β-catenin protects against hepatotoxin
DDC-induced liver injury and inhibits Foxo3 expression thus
inhibiting oxidative stress-induced apoptosis.14 In the rat
sensory epithelium OC1 cell line, Wnt/β-catenin protects the
OC1 cells against cisplatin-induced cell death.41 Here, we
found that after neomycin treatment overexpression of
β-catenin in mouse HCs significantly inhibits the expression
of Foxo3 and Bim (Figure 8), enhances the expression of
antioxidant enzymes (Figure 9), reduces ROS accumulation
(Figure 9), and inhibits caspase-induced apoptosis (Figures 6
and 7), and thus protects HCs against neomycin-induced
damage (Figures 3 and 5). These results indicate that
Wnt/β-catenin has an important role in protecting against
neomycin-induced HC damage.
Aminoglycosides are widely used in clinics to treat bacterial
infections, but all aminoglycosides have ototoxic side effects,
which limit their clinical use. Mammalian sensory HCs have
many mitochondria and high oxygen consumption, which
makes them very sensitive to oxidative stress, especially
when challenged by external stimulation such as noise or
aminoglycosides.42 Here, we found that knockout of β-catenin
in HCs increases caspase-mediated HC apoptosis after
neomycin treatment and that overexpression of β-catenin in
HCs inhibits caspase-mediated HC apoptosis after neomycin
treatment (Figures 6 and 7). Besides the canonical Wnt/
β-catenin pathway, two β-catenin-independent pathways have
been described, including the Wnt/Ca2+ and Wnt/PCP (planar
cell polarity) pathways.43,44 In the zebrafish lateral line, after
exposure to aminoglycosides, dying HCs undergo a transient
increase in intracellular Ca2+ that occurs shortly after
mitochondrial membrane potential collapse. Inhibition of
intracellular Ca2+ elevation mitigates toxic effects of amino-
glycoside exposure.45 Under physiological conditions, cal-
cium and ROS act as signaling molecules inside the cell and
their pathways can interact. However, under pathological
conditions dysfunction in either of the systems might affect the
other system thus potentiating harmful effects that might
contribute to cell death.46 The role of non-canonical Wnt
signaling in cochlear HC survival and the role of calcium
overload in β-catenin deficiency-induced increased HC
susceptibility to neomycin need to be investigated in the future.
Previous studies reported that Wnt/β-catenin is protective
against oxidative stress-induced apoptosis through inhibition
of Foxo3 in the liver, bones, and SH-SY5Y cells.14,15,47 There
are also other papers that suggest that Wnt has the opposite
effect on mitochondria. Yoon et al.48 reports that increased
Wnt signals are a potent activator of mitochondrial biogenesis
and ROS generation, leading to DNA damage and accelera-
tion of cellular senescence in primary cells.48 This might be
because Wnt signaling has diverse functions in different
environments and stages, and sometimes these effects are in
opposition to each other. For example, promoting proliferation
and promoting differentiation are usually two opposing effects,
and during embryonic stages Wnt/β-catenin signaling pro-
motes proliferation during early mitotic phases of development
and also promotes HC differentiation in the differentiating
organ of Corti.3 Here, we found that neomycin-induced HC
damage was accompanied by Foxo3 upregulation and
mitochondrial ROS accumulation. Knockout of β-catenin in
HCs upregulated Foxo3 expression and increased the
accumulation of ROS even more, while overexpression of
β-catenin in HCs inhibited Foxo3 expression and decreased
the accumulation of ROS after neomycin injury. This finding
indicates that Wnt/β-catenin protects HCs against neomycin
injury by regulating Foxo3 expression and controlling ROS
levels.
In summary, we showed that deletion of β-catenin in HCs
increases neomycin-induced HC loss. Next, we reported
that overexpression of β-catenin in HCs protects against
neomycin-induced HC loss. Last, we demonstrated that
Wnt/β-catenin signaling in HCs regulates Foxo3 expression,
antioxidant enzymes, and ROS levels, thus protecting HCs
against caspase-mediated apoptosis after neomycin injury.
Our data suggest that Wnt/β-catenin signaling is essential for
HC protection against neomycin-induced HC loss, and thus
might be a new therapeutic target for the prevention of
aminoglycoside-induced HC death.
Materials and Methods
Mouse models and treatments. We used C57BL/6 J WT mice and trans-
genic mice in the C57BL/6 J background. β-Cateninflox(exon3) mice49 were gener-
ously provided by Mark Taketo (Kyoto University, Kyoto, Japan), β-cateninflox(exon2–6)
mice50 were ordered from The Jackson Laboratory (Bar Harbor, ME, USA; JAX
number 004152), Rosa26-tdTomato mice51 were ordered from The Jackson
Laboratory (JAX number 007914), and Gfi1-Cre mice24 were generously provided
by Lin Gan (University of Rochester, Rochester, NY, USA). For β-cateninflox(exon2–6)
mice, Cre-induced recombination at the LoxP sites flanks exons 2–6 of β-catenin,
and Cre activation results in a β-catenin-null allele.50 For β-cateninflox(exon3) mice,
β-Catenin:exon3 encodes the GSK3 phosphorylation sites for degradation, and
exon 3 is not functionally required for β-catenin transcriptional activity. Deletion of
β-catenin:exon3 therefore results in increased levels of β-catenin.
Mice were housed with open access to food and water at the Experimental Animal
Center, Shanghai Medical College of Fudan University, China. Postnatal day (P) 0
was defined as the day of birth. Mice received a daily subcutaneous injection of
neomycin (200 mg/kg) or sterile saline from P7 to P14. This study was carried out in
strict accordance with the 'Guiding Directive for Humane treatment of Laboratory
Animals' issued by the Chinese National Ministry of Science and Technology in
September 2006. All experiments were approved by the Shanghai Medical
Experimental Animal Administrative Committee (Permit Number: 2009-0082). All
efforts were made to minimize suffering and reduce the number of animals used.
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Organotypic culture of neonatal mice cochlea. The mice were killed
at P2, then the cochlear sensory epithelium was isolated and seeded intact on a
glass coverslip coated with Cell-Tak (BD Biosciences, Franklin Lakes, NJ, USA).52
The explanted cochleae were treated with 1 mM neomycin (Sigma-Aldrich, St. Louis,
MO, USA) and/or 5 μM Bio (Sigma-Aldrich) or 20 mM NAC (Sigma-Aldrich). PBS
was used as the vehicle control.
ABR test. The hearing thresholds of the mice were examined with the ABR test.
In this test, changes in the electrical activity of the brain in response to sound were
recorded via electrodes that were placed on the scalp of the mice. Animals were
anesthetized with ketamine (100 mg/kg) and xylazine (25 mg/kg) and placed on a
thermostatic heating pad in a sound-attenuating chamber to maintain their body
temperatures at 38 °C. Frequency-specific auditory responses were measured
using the Tucker-Davis Technology system III (Tucker-Davies Technologies,
Gainesville, FL, USA) as previously described.53 All ABR tests were performed
on mice older than P21.
Tissue preparation for quantitative RT-PCR and western blot.
After killing the mice, the otic capsule was immediately isolated, rapidly frozen in
liquid nitrogen, and stored at − 70 °C until further processing. To obtain the total
RNA, 10 cochleae were pooled in TRIzol (Invitrogen, Carlsbad, CA, USA) following
the manufacturer’s instructions. The RNA concentration was measured with a Bio-
Rad spectrophotometer (Applied Biosystems, Foster City, CA, USA). cDNA was
synthesized from 1 μg total RNA by reverse transcription using the GoScript
Reverse Transcription System (Promega, Madison, WI, USA) following the
manufacturer’s protocols. qPCR was performed using GoTaq qPCR Master Mix
(Promega) on a Bio-Rad 7500 detection system (Applied Biosystems, Foster City,
CA, USA). GAPDH was used as a housekeeping gene for control purposes. Primer
sequences are listed in Supplementary Table 6. For protein extraction, 10 cochleae
were pooled in 100 μl RIPA lysis buffer with 1% PMSF, sonicated, incubated on ice
for 30 min, and stored at − 80 °C. Extracts were boiled with 5 × loading buffer,
subjected to PAGE (Mini-Protean TGX Systems; Bio-Rad, Hercules, CA, USA),
transferred onto an Immobilon-P membrane (Millipore, Bedford, MA, USA), probed
with anti-Foxo3 antibody (Cell Signaling Technology, Danvers, MA, USA), anti-β-
catenin (BD Biosciences), and anti-GAPDH (Kangchen Biotech, Shanghai, China)
and finally incubated with HRP-conjugated secondary antibodies. Signal was
detected with the Supersignal West Femto Trial Kit (Thermo Fisher Scientific,
Rockford, IL, USA) on a FluorChem M system (ProteinSimple, San Jose, CA, USA).
Immunofluorescence. After fixation, cochlear samples were blocked with
10% normal donkey serum in 10 mM phosphate-buffered saline (PBS, pH 7.4) with
0.3% Triton X-100 for 1 h at room temperature and then incubated with primary
antibody overnight at 4 °C. The next day, the tissues were incubated for 2 h at 4 °C
with 488- or 594-conjugated donkey secondary antibody (Invitrogen) and DAPI
(Sigma-Aldrich). Omission of primary antibody served as the negative control. The
following primary antibodies were used: anti-β-catenin (BD Biosciences), anti-
myosin VIIA (Myosin7a) (Proteus Biosciences, Ramona, CA, USA), anti-cleaved
caspase-3 (Cell Signaling Technology), anti-Foxo3 (Cell Signaling Technology), anti-
Parvalbumin (Sigma-Aldrich), TUNEL (Roche, Indianapolis, IN, USA), and MitoSOX
Red (Life Technologies, Rockford, IL, USA). Cochleae were dissected into apical,
middle, and basal turns, and images were taken using a Leica SP5 confocal
fluorescence microscope (Leica Microsystems, Biberach, Germany).
Fluorescence activated cell sorting. Gfi1-Cre/β-cateninflox(exon2–6)/
Rosa26-tdTomato or Gfi1-Cre/β-cateninflox(exon3)/Rosa26-tdTomato mice (P2) were
dissected out to isolate ∼ 20–40 cochleae, and then trypsinized with prewarmed
0.125% trypsin/EDTA (Invitrogen) at 37 °C for 8 min. Soybean trypsin inhibitor
(Worthington Biochem, Lakewood, CO, USA) was added to terminate the reaction
followed by mechanical trituration with blunt tips and pipetting up and down up to
80–100 times. Suspended cells were percolated through a 40-μm cell strainer
before fluorescence activated cell sorting (FACS). tdTomato-positive HCs were
sorted out on a BD FACS Aria III (BD Biosciences) using the tdTomato channel.
Cell counts. For HC quantification in the neomycin-treated samples, we imaged
the entire cochlea using a 40 × 3 objective and counted the Myosin7a+ HCs
that remained. The same procedure was used to quantify cleaved caspase-3+/
Myosin7a+, TUNEL+/Myosin7a+ cells, and myosin7a+/MitoSOX Red+ cells. For
all experiments, only one cochlea from each mouse was used for immuno-
fluorescence and quantification. Thus, n represents the number of mice examined.
Statistical analyses. Statistical analyses were conducted using Microsoft
Excel and GraphPad Prism software (GraphPad Software, La Jolla, CA ,USA). Data
were expressed as mean± S.E.M. ABR thresholds were analyzed by two-way
ANOVA followed by a Newman–Keuls post hoc test. Immunofluorescence analysis
was performed with a two-tailed, unpaired Student’s t-test when comparing two
groups or with a one-way ANOVA followed by a Dunnett’s multiple comparisons test
when comparing more than two groups. Po0.05 was considered as statistically
significant.
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